Biosyent Inc (OTCPK:BIOYF)
$ 7.35 0.16 (2.23%) Market Cap: 88.74 Mil Enterprise Value: 68.12 Mil PE Ratio: 16.90 PB Ratio: 3.45 GF Score: 98/100

Q2 2021 Biosyent Inc Earnings Call Transcript

Aug 25, 2021 / NTS GMT
Release Date Price: $6.12 (-2.99%)
RenÃ;C. Goehrum
BioSyent Inc. - Chairman, CEO & President

© -

Hello, and welcome to the BioSyent Q2 and First Half 2021 Results Presentation. My name is René Goehrum, and I'm the President and CEO of the company. I want to start today's presentation with a look at our sales, EBITDA and net income after tax for the quarter ended June 30, 2021.

So the quarter represented our 44th consecutive profitable quarter, dating back all the way to Q2 of 2010 when the company turned profitable. Sales were just under $7.3 million, up 53% versus a year ago, and a couple of things I would like to bring to your attention. In the year ago second quarter, we had some softness, and I would take you back to Wave 1 of COVID. In March of 2020, we had a surge in sales, both for wholesale distribution of pharmacies and the hospitals doing some stockpiling. So what we found there was exceptionally high sales in March of 2020 and then a sharp dropoff in April of 2020 and then a building back in May. And June last year is kind of business normalized, and then we proceeded to grow the business over that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot